Role of DUOPA™ (carbidopa and levodopa Enteral Suspension) in Patients with Deep Brain Stimulation

被引:0
|
作者
Tauer, Aaron
Govindarajan, Raghav
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
57
引用
收藏
页码:S32 / S33
页数:2
相关论文
共 50 条
  • [31] Intestinal Levodopa/Carbidopa Infusion as a Therapeutic Option for Freezing of Gait After Deep Brain Stimulation in Parkinson's Disease
    Gonzalez, B.
    Jauma, S.
    Gomez, R.
    Marzal, C.
    Calopa, M.
    MOVEMENT DISORDERS, 2019, 34 : S43 - S43
  • [32] Successful Treatment of Levodopa/Carbidopa Intestinal Gel Associated "Biphasic-like" Dyskinesia with Pallidal Deep Brain Stimulation
    Mulroy, Eoin
    Leta, Valentina
    Zrinzo, Ludvic
    Foltynie, Thomas
    Chaudhuri, K. Ray
    Limousin, Patricia
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2021, : 1 - 2
  • [33] Dyskinesia-Hyperpyrexia Syndrome in Parkinson's disease with Deep Brain Stimulation and high dose levodopa/carbidopa and entacapone
    Novelli, Alessio
    Di Vico, Ilaria Antonella
    Terenzi, Federica
    Sorbi, Sandro
    Ramat, Silvia
    PARKINSONISM & RELATED DISORDERS, 2019, 64 : 352 - 353
  • [34] Pharmacokinetic model of oral levodopa and role of carbidopa in parkinsonian patients
    Mizutani, Y
    Okada, Y
    Ogawa, M
    Hasegawa, T
    Nabeshima, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1995, 18 (12) : 1729 - 1737
  • [35] Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson’s Disease: Clinical Trial Post Hoc Analyses
    Rajesh Pahwa
    Jason Aldred
    Niodita Gupta
    Emi Terasawa
    Viviana Garcia-Horton
    David R. Steffen
    Prasanna L. Kandukuri
    Vivek S. Chaudhari
    Yash J. Jalundhwala
    Yanjun Bao
    Pavnit Kukreja
    Stuart H. Isaacson
    Neurology and Therapy, 2022, 11 : 711 - 723
  • [36] Levodopa Carbidopa Intestinal Gel in Patients with Deep Brain Stimulation in Parkinson's disease- First case series from Middle East Region
    Mittal, S.
    AlDakheel, A.
    Mohammed, W.
    Alkhairallah, T.
    Klassen, B.
    Thomas, M.
    Maiti, T.
    Wasti, S.
    MOVEMENT DISORDERS, 2022, 37 : S437 - S437
  • [37] Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson's Disease: Clinical Trial Post Hoc Analyses
    Pahwa, Rajesh
    Aldred, Jason
    Gupta, Niodita
    Terasawa, Emi
    Garcia-Horton, Viviana
    Steffen, David R.
    Kandukuri, Prasanna L.
    Chaudhari, Vivek S.
    Jalundhwala, Yash J.
    Bao, Yanjun
    Kukreja, Pavnit
    Isaacson, Stuart H.
    NEUROLOGY AND THERAPY, 2022, 11 (02) : 711 - 723
  • [38] Benefits of Levodopa-Carbidopa Intestinal Gel Infusion in Patients with Parkinson's Disease Experiencing Gait Dysfunction Following Subthalamic Deep Brain Stimulation
    Kimber, Thomas Edmund
    Zhuang, YiZhong
    Thompson, Philip Douglas
    JOURNAL OF MOVEMENT DISORDERS, 2019, 12 (03) : 192 - 194
  • [39] A prospective comparison of apomorphine, STN deep brain stimulation and levodopa-carbidopa intestinal gel therapy for motor fluctuations in PD
    Chiang, H. L.
    Chang, F.
    Tsui, D.
    Tai, Y.
    Ha, A.
    Mahant, N.
    Griffith, J.
    Galea, D.
    Kim, S.
    Cruse, B.
    Morales-Briceno, H.
    MOVEMENT DISORDERS, 2017, 32
  • [40] Comment on: Successful Treatment of Levodopa/Carbidopa Intestinal Gel Associated "Biphasic-Like" Dyskinesia with Pallidal Deep Brain Stimulation
    Gupta, Harsh V.
    Sharma, Vibhash D.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2021, 8 (05): : 812 - 813